Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cannabinoid pharmacology: the first 66 years.
Genzyme’s Lemtrada® approved in Mexico for treatment of multiple sclerosis
Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis.
First-line disease-modifying therapies in paediatric multiple sclerosis: a comprehensive overview.
Improved patient-reported health impact of multiple sclerosis: The ENABLE study of PR-fampridine.
Axonal transport analysis using Multitemporal Association Tracking.
Consensus statements from a panel of u.s. Managed care pharmacists and physicians for management of multiple sclerosis agents.
Disparate in vivo efficacy of FTY720 in xenograft models of Philadelphia positive and negative B-lineage acute lymphoblastic leukemia.
Cannabinoid CB2 receptors and fatty acid amide hydrolase are selectively overexpressed in neuritic plaque-associated glia in Alzheimer's disease brains.
Distraction adds to the cognitive burden in multiple sclerosis.
Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosis.
Autologous haematopoietic stem cell transplantation for aggressive multiple sclerosis: the Swedish experience.
Riluzole-induced block of voltage-gated Na+ current and activation of BKCa channels in cultured differentiated human skeletal muscle cells.
A Population Approach to Characterize Interferon Beta-1b Effect on Contrast Enhancing Lesions in Patients With Relapsing Remitting Multiple Sclerosis.
1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization.
1,25-Dihydroxyvitamin D3 inhibits the differentiation and migration of T(H)17 cells to protect against experimental autoimmune encephalomyelitis.
Distinct features between longitudinally extensive transverse myelitis presenting with and without anti-Aquaporin 4 antibodies.
No Association Between Conventional Brain MR Imaging and Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis.
Assessing walking disability in multiple sclerosis.
The path to self-management: a qualitative study involving older people with multiple sclerosis.
Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility.
Safety and Tolerability of Glatiramer Acetate (GLACIER)
Extensive loss of connexins in Baló's disease: evidence for an auto-antibody-independent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction.
Preclinical retinal neurodegeneration in a model of multiple sclerosis.
Extracranial Venous Drainage Patterns in Patients with Multiple Sclerosis and Healthy Controls.
Pages
« first
‹ previous
…
138
139
140
141
142
143
144
145
146
…
next ›
last »